Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122814225 | 12281422 | 5 | F | 201512 | 20160909 | 20160419 | 20160916 | EXP | US-BIOGEN-2016BI00219977 | BIOGEN | 52.01 | YR | F | Y | 117.59000 | KG | 20160916 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122814225 | 12281422 | 1 | PS | AVONEX | INTERFERON BETA-1A | 1 | Intramuscular | 103628 | 30 | UG | SOLN FOR INJECT IN PRE-FILLED SYRINGE | /wk | |||||||
| 122814225 | 12281422 | 2 | SS | AVONEX | INTERFERON BETA-1A | 1 | Unknown | 103628 | UNKNOWN | ||||||||||
| 122814225 | 12281422 | 3 | SS | AVONEX | INTERFERON BETA-1A | 1 | Unknown | 103628 | UNKNOWN | ||||||||||
| 122814225 | 12281422 | 4 | C | PLAVIX | CLOPIDOGREL BISULFATE | 1 | Oral | 0 | 75 | MG | TABLETS | QD | |||||||
| 122814225 | 12281422 | 5 | C | GABAPENTIN. | GABAPENTIN | 1 | Oral | 1500 MG IN AM AND PM?1200 MG IN NOON | 0 | 600 | MG | TABLETS | TID | ||||||
| 122814225 | 12281422 | 6 | C | LANTUS | INSULIN GLARGINE | 1 | Subcutaneous | IN THE MORNING | 0 | 70 | IU | SOLUTION FOR INJECTION | QD | ||||||
| 122814225 | 12281422 | 7 | C | TYLENOL | ACETAMINOPHEN | 1 | Oral | 3 TABLETS AS NEEDED | 0 | 325 | MG | TABLETS | QD | ||||||
| 122814225 | 12281422 | 8 | C | IBUPROFEN. | IBUPROFEN | 1 | Oral | AS NEEDED | 0 | 800 | MG | TABLETS | BID | ||||||
| 122814225 | 12281422 | 9 | C | BACLOFEN. | BACLOFEN | 1 | Oral | 0 | 20 | MG | TABLETS | QID | |||||||
| 122814225 | 12281422 | 10 | C | SIMVASTATIN. | SIMVASTATIN | 1 | Oral | AT NIGHT | 0 | 80 | MG | TABLETS | QD | ||||||
| 122814225 | 12281422 | 11 | C | OXYCODONE HYDROCHLORIDE. | OXYCODONE HYDROCHLORIDE | 1 | Oral | AS NEEDED | 0 | 15 | MG | TABLETS | Q4H | ||||||
| 122814225 | 12281422 | 12 | C | GABAPENTIN. | GABAPENTIN | 1 | Oral | 0 | 300 | MG | CAPSULES | BID | |||||||
| 122814225 | 12281422 | 13 | C | GABAPENTIN. | GABAPENTIN | 1 | Oral | 0 | 600 | MG | CAPSULES | TID | |||||||
| 122814225 | 12281422 | 14 | C | FUROSEMIDE. | FUROSEMIDE | 1 | Oral | 0 | 80 | MG | TABLETS | QD | |||||||
| 122814225 | 12281422 | 15 | C | Metformin HCL | METFORMIN HYDROCHLORIDE | 1 | Oral | 0 | 100 | MG | TABLETS | BID | |||||||
| 122814225 | 12281422 | 16 | C | AMBIEN | ZOLPIDEM TARTRATE | 1 | Oral | AT BEDTIME | 0 | 10 | MG | TABLETS | QD | ||||||
| 122814225 | 12281422 | 17 | C | HUMALOG | INSULIN LISPRO | 1 | Oral | USE AS DIRECTED; 100 UNIT BOTTLE | 0 | SOLUTION FOR INJECTION | |||||||||
| 122814225 | 12281422 | 18 | C | Sulfamethoxazole TMP DS | 2 | Oral | 0 | 800 | MG | TABLETS | BID | ||||||||
| 122814225 | 12281422 | 19 | C | Sulfamethoxazole TMP DS | 2 | Oral | 0 | 160 | MG | TABLETS | BID | ||||||||
| 122814225 | 12281422 | 20 | C | BXN Mouthwash | 2 | Oral | AS NEEDED | 0 | 10 | MG | SUSPENSION | Q4H | |||||||
| 122814225 | 12281422 | 21 | C | BUSPIRONE HCL | BUSPIRONE HYDROCHLORIDE | 1 | Oral | 0 | 5 | MG | TABLETS | TID | |||||||
| 122814225 | 12281422 | 22 | C | PANTOPRAZOLE SODIUM. | PANTOPRAZOLE SODIUM | 1 | Oral | 0 | 20 | MG | TABLETS | QD | |||||||
| 122814225 | 12281422 | 23 | C | HYDROCODONE BITARTRATE AND ACETAMINOPHEN | ACETAMINOPHENHYDROCODONE BITARTRATE | 1 | Oral | PRN | 0 | 10 | MG | TABLETS | Q4H | ||||||
| 122814225 | 12281422 | 24 | C | HYDROCODONE BITARTRATE AND ACETAMINOPHEN | ACETAMINOPHENHYDROCODONE BITARTRATE | 1 | Oral | PRN | 0 | 325 | MG | TABLETS | Q4H | ||||||
| 122814225 | 12281422 | 25 | C | VITAMIN D | CHOLECALCIFEROL | 1 | Oral | FOR 16 WEEKS | 0 | 50000 | IU | CAPSULE | /wk | ||||||
| 122814225 | 12281422 | 26 | C | RITALIN | METHYLPHENIDATE HYDROCHLORIDE | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 122814225 | 12281422 | 27 | C | RITALIN | METHYLPHENIDATE HYDROCHLORIDE | 1 | Oral | PRN | 0 | 325 | MG | TABLETS | Q4H |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 122814225 | 12281422 | 1 | Multiple sclerosis |
| 122814225 | 12281422 | 4 | Product used for unknown indication |
| 122814225 | 12281422 | 5 | Product used for unknown indication |
| 122814225 | 12281422 | 6 | Product used for unknown indication |
| 122814225 | 12281422 | 7 | Product used for unknown indication |
| 122814225 | 12281422 | 8 | Product used for unknown indication |
| 122814225 | 12281422 | 9 | Product used for unknown indication |
| 122814225 | 12281422 | 10 | Product used for unknown indication |
| 122814225 | 12281422 | 11 | Pain |
| 122814225 | 12281422 | 12 | Product used for unknown indication |
| 122814225 | 12281422 | 14 | Product used for unknown indication |
| 122814225 | 12281422 | 15 | Product used for unknown indication |
| 122814225 | 12281422 | 16 | Product used for unknown indication |
| 122814225 | 12281422 | 17 | Product used for unknown indication |
| 122814225 | 12281422 | 18 | Product used for unknown indication |
| 122814225 | 12281422 | 20 | Oral pain |
| 122814225 | 12281422 | 21 | Product used for unknown indication |
| 122814225 | 12281422 | 22 | Product used for unknown indication |
| 122814225 | 12281422 | 23 | Pain |
| 122814225 | 12281422 | 25 | Product used for unknown indication |
| 122814225 | 12281422 | 26 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 122814225 | 12281422 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 122814225 | 12281422 | Arthropod bite | |
| 122814225 | 12281422 | Cellulitis | |
| 122814225 | 12281422 | Contusion | |
| 122814225 | 12281422 | Drug hypersensitivity | |
| 122814225 | 12281422 | Erythema | |
| 122814225 | 12281422 | Escherichia pyelonephritis | |
| 122814225 | 12281422 | Feeling abnormal | |
| 122814225 | 12281422 | Furuncle | |
| 122814225 | 12281422 | Gait disturbance | |
| 122814225 | 12281422 | Loss of consciousness | |
| 122814225 | 12281422 | Medical induction of coma | |
| 122814225 | 12281422 | Neuropathy peripheral | |
| 122814225 | 12281422 | Pain in extremity | |
| 122814225 | 12281422 | Paraesthesia | |
| 122814225 | 12281422 | Renal impairment | |
| 122814225 | 12281422 | Vomiting | |
| 122814225 | 12281422 | Wound |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 122814225 | 12281422 | 1 | 20130613 | 20150403 | 0 | |
| 122814225 | 12281422 | 2 | 20150511 | 201512 | 0 | |
| 122814225 | 12281422 | 3 | 20160624 | 0 |